Challenges and Solutions during the COVID Pandemic for Patient Retention and Physician Engagement in the Phase 3 ATLAS Study of Apalutamide Added to Androgen Deprivation Therapy (ADT) in High-Risk Localized or Locally Advanced Prostate Cancer (HRLPC)

Sandler, H. M.; Shore, N.; Dearnaley, D.; Freedland, S. J.; Smith, M. R.; Rosales, R.; Brookman-May, S. D.; Dicker, A. P.; McKenzie, M. R.; Bossi, A.; Widmark, A.; Wiegel, T.; Martin, J.; Miladinovic, B.; Lefresne, F.; Ciprotti, M.; McCarthy, S. A.; Mundle, S. D.; Tombal, B. F.; Feng, F. Y.

Sandler, H. M.; Shore, N.; Dearnaley, D.; Freedland, S. J.; Smith, M. R.; Rosales, R.; Brookman-May, S. D.; Dicker, A. P.; McKenzie, M. R.; Bossi, A.; Widmark, A.; Wiegel, T.; Martin, J.; Miladinovic, B.; Lefresne, F.; Ciprotti, M.; McCarthy, S. A.; Mundle, S. D.; Tombal, B. F.; Feng, F. Y..

International Journal of Radiation Oncology, Biology, Physics ; 114(3):e244-e245, 2022.

Article in English | CINAHL | ID: covidwho-2036097

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: CINAHL Type of study: Prognostic study Language: English Journal: International Journal of Radiation Oncology, Biology, Physics Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google